Nexalin Technology Inc. (NASDAQ:NXL) — Market Cap & Net Worth
Market Cap & Net Worth: Nexalin Technology Inc. (NXL)
Nexalin Technology Inc. (NASDAQ:NXL) has a market capitalization of $7.25 Million ($7.25 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27797 globally and #5654 in its home market, demonstrating a -21.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nexalin Technology Inc.'s stock price $0.39 by its total outstanding shares 20581646 (20.58 Million). Review debt load of Nexalin Technology Inc. to assess the company's total debt and financial obligations.
Nexalin Technology Inc. Market Cap History: 2022 to 2026
Nexalin Technology Inc.'s market capitalization history from 2022 to 2026. Data shows change from $15.42 Million to $8.09 Million (-37.20% CAGR).
Index Memberships
Nexalin Technology Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #806 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #2591 of 3165 |
Weight: Nexalin Technology Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nexalin Technology Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nexalin Technology Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
38.07x
Nexalin Technology Inc.'s market cap is 38.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $15.42 Million | $1.32 Million | -$1.70 Million | 11.67x | N/A |
| 2023 | $8.34 Million | $110.75K | -$4.65 Million | 75.27x | N/A |
| 2024 | $54.79 Million | $168.72K | -$7.61 Million | 324.73x | N/A |
| 2025 | $11.48 Million | $301.65K | -$8.22 Million | 38.07x | N/A |
Competitor Companies of NXL by Market Capitalization
Companies near Nexalin Technology Inc. in the global market cap rankings as of June 18, 2026.
Key companies related to Nexalin Technology Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $157.58 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $118.86 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #244 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $157.58 Billion | $90.62 |
| #205 | Stryker Corporation | NYSE:SYK | $118.86 Billion | $310.58 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #244 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $81.32 |
Nexalin Technology Inc. Historical Marketcap From 2022 to 2026
Between 2022 and today, Nexalin Technology Inc.'s market cap moved from $15.42 Million to $ 8.09 Million, with a yearly change of -37.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.09 Million | -29.57% |
| 2025 | $11.48 Million | -79.04% |
| 2024 | $54.79 Million | +557.28% |
| 2023 | $8.34 Million | -45.93% |
| 2022 | $15.42 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Nexalin Technology Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.25 Million USD |
| MoneyControl | $7.25 Million USD |
| MarketWatch | $7.25 Million USD |
| marketcap.company | $7.25 Million USD |
| Reuters | $7.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 a… Read more